Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

3.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.0K
3.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Overview of Cell Death01:30

Overview of Cell Death

7.7K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.7K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

121
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
121
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroprotective potential of a TrkB-FL-derived cell-penetrating peptide in cochlear synaptopathy and noise-induced hearing loss.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Urinary detection of therapy-induced senescence and fibrosis using an injectable albumin-based nanoprobe.

Nature aging·2026
Same author

Cellular reprogramming beyond pluripotency.

Trends in molecular medicine·2026
Same author

Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome.

Nature aging·2026
Same author

<i>Rps19</i> <sup>R67∆</sup> mutation creates a model of Diamond-Blackfan anemia and reveals downstream mediators of p53 pathway.

HemaSphere·2026
Same author

NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum.

EMBO molecular medicine·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Same journal

Systematic discovery of pathogen effector functions across human pathogens and pathways.

Cell·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

8.9K

Programmed cell senescence during mammalian embryonic development.

Daniel Muñoz-Espín1, Marta Cañamero, Antonio Maraver

  • 1Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid E28029, Spain.

Cell
|November 19, 2013
PubMed
Summary
This summary is machine-generated.

Cellular senescence, a process that stops cell growth, occurs during mammalian embryonic development. This programmed senescence aids tissue remodeling and may be the evolutionary origin of damage-induced senescence.

More Related Videos

Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.3K
Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

17.2K

Related Experiment Videos

Last Updated: May 5, 2026

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

8.9K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.3K
Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

17.2K

Area of Science:

  • Developmental Biology
  • Cellular Biology
  • Aging Research

Background:

  • Cellular senescence typically halts proliferation in damaged cells, with implications for cancer and aging.
  • The role of senescence during normal embryonic development has been less understood.

Purpose of the Study:

  • To investigate the occurrence and mechanisms of cellular senescence during mammalian embryonic development.
  • To determine the functional role of developmentally programmed senescence in tissue remodeling.

Main Methods:

  • Analysis of senescence markers in embryonic tissues, specifically the mesonephros and endolymphatic sac.
  • Genetic manipulation to assess the dependence of senescence on specific pathways (p21, p53, TGF-β/SMAD, PI3K/FOXO).
  • Investigation of the consequences of senescence absence on embryonic development.

Main Results:

  • Cellular senescence was identified in multiple embryonic locations, including the mesonephros and inner ear's endolymphatic sac.
  • Senescence was strictly dependent on p21 but independent of DNA damage or p53.
  • Developmentally programmed senescence facilitates macrophage infiltration, cell clearance, and tissue remodeling, with p21 absence leading to developmental defects.

Conclusions:

  • Developmentally programmed senescence plays a crucial role in embryonic tissue remodeling.
  • This programmed senescence is mechanistically regulated by specific signaling pathways and is conserved in human embryos.
  • The study proposes that developmentally programmed senescence is the evolutionary precursor to damage-induced senescence.